Outset Medical, Inc.
OM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $114 | $130 | $115 | $103 |
| % Growth | -12.8% | 13% | 12.4% | – |
| Cost of Goods Sold | $75 | $101 | $98 | $95 |
| Gross Profit | $39 | $29 | $18 | $8 |
| % Margin | 33.9% | 22.2% | 15.5% | 7.4% |
| R&D Expenses | $38 | $57 | $49 | $37 |
| G&A Expenses | $43 | $45 | $41 | $36 |
| SG&A Expenses | $114 | $141 | $130 | $101 |
| Sales & Mktg Exp. | $70 | $96 | $89 | $65 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $152 | $199 | $179 | $138 |
| Operating Income | -$113 | -$170 | -$161 | -$131 |
| % Margin | -99.7% | -130.2% | -139.6% | -127.2% |
| Other Income/Exp. Net | -$14 | -$3 | -$2 | -$1 |
| Pre-Tax Income | -$127 | -$172 | -$163 | -$132 |
| Tax Expense | $0 | $1 | $0 | $0 |
| Net Income | -$128 | -$173 | -$163 | -$132 |
| % Margin | -112.6% | -132.5% | -141.2% | -128.6% |
| EPS | -2.46 | -3.48 | -3.38 | -2.89 |
| % Growth | 29.3% | -3% | -17% | – |
| EPS Diluted | -2.46 | -3.48 | -3.38 | -2.89 |
| Weighted Avg Shares Out | 3 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 3 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $10 | $3 | $0 |
| Interest Expense | $24 | $13 | $4 | $2 |
| Depreciation & Amortization | $6 | $6 | $6 | $6 |
| EBITDA | -$98 | -$154 | -$153 | -$125 |
| % Margin | -86.1% | -118% | -132.4% | -121.7% |